En Es
Categories

Industry News

Philips lanza un programa emergente de colaboración en IA

By Medimaging en español staff writers
07 Nov 2018

Imagen: El nuevo programa de inteligencia artificial se enfoca en la aplicación de herramientas de soporte de decisiones clínicas y de flujo de trabajo basadas en la inteligencia artificial (Fotografía cortesía de iStock).Royal Philips (Ámsterdam, Países Bajos) lanzó su primer programa global de colaboración emergente que involucra los centros de innovación de la compañía en Cambridge, EUA, Eindhoven, Países Bajos, Bangalore, India y Shanghái, China, centrados en la aplicación. de inteligencia artificial (IA) en salud. El programa se centra en la aplicación de herramientas de apoyo a la toma de decisiones clínicas basadas en la IA, como la interpretación, el análisis y la integración de imágenes, y las herramientas de flujo de trabajo, como los planes de tratamiento inteligente para radiología, ultrasonido y oncología.

Philips pretende utilizar una combinación de inteligencia artificial y otras tecnologías con conocimiento del contexto clínico y operacional en el que se utilizan, un enfoque centrado en las personas al que se refiere como "inteligencia adaptativa". Su objetivo es desarrollar soluciones integradas que se adapten a las necesidades de los proveedores de atención médica y que estén integradas en sus flujos de trabajo. Para respaldar la adopción de la inteligencia artificial en los dominios clave de la atención médica, Philips ha desarrollado una plataforma de inteligencia artificial para la asistencia médica: Philips HealthSuite Insights, que proporciona herramientas y tecnologías específicas de la asistencia médica para abordar el proceso completo de creación, mantenimiento, implementación y escalado de soluciones de inteligencia artificial. Las herramientas y tecnologías disponibles a través de HealthSuite Insights ya permiten el aprendizaje automático y las aplicaciones de aprendizaje profundo en las soluciones de diagnóstico por imágenes de Philips, las soluciones de telesalud y las ofertas de oncología y genómica.

Philips ha extendido sus programas de colaboración a empresas de tecnología de la salud y actividades de capital de riesgo. Philips HealthWorks acelera la innovación de vanguardia a través del compromiso de emprendimiento interno participación externa de la empresa emergente. El programa permite a Philips evaluar, fomentar y monitorizar las prometedoras empresas emergentes en sus primeras etapas para posibles colaboraciones futuras, así como proporcionar a la compañía una visión detallada de los desarrollos más recientes en tecnología de la salud en todo el mundo.

De los 750 solicitantes, Philips ha seleccionado las 19 empresas emergentes más prometedoras para incluirlas en el programa de incubadoras para empresas nuevas. Durante el programa intensivo de 12 semanas 'IA en la atención de salud para Radiología, Ultrasonido y Oncología', Philips se involucrará simultáneamente con las empresas emergentes de 14 países diferentes, con el fin de validar sus propuestas, ayudar a construir, probar y escalar sus ideas, y explorar posibles colaboraciones. Las nuevas empresas seleccionadas se beneficiarán de los conocimientos y la experiencia de Philips en el campo de la atención médica profesional, y obtendrán acceso a la experiencia en el ecosistema de innovación de la empresa, que incluye socios de hospitales, académicos, industriales y financieros.

"En Philips, usamos tecnología inteligente para mejorar la salud de las personas en todo el proceso de salud, desde una vida saludable y la prevención hasta el diagnóstico, el tratamiento y la atención domiciliaria, al mismo tiempo que aumentamos la eficiencia de la prestación de atención médica", dijo Alberto Prado, director de Philips Healthworks. "Ya trabajamos estrechamente con socios clínicos para desarrollar soluciones habilitadas para la IA que se basan en la investigación científica y se validan en la práctica clínica. Este nuevo programa de colaboración reconoce el papel que desempeñan las empresas de nueva creación para llevar al mercado innovaciones de vanguardia en el sector de la salud".

Enlace relacionado:
Royal Philips



E-mail Print
FaceBook Twitter Google+ Linked in

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare with a strong presence in cardio-pulmonary, oncology and women’s health
More info

More articles about Philips Healthcare

09 Nov 2021
Philips Acquires Medical Technology Company Cardiologs to Expand Cardiac Diagnostics and Monitoring Portfolio
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Cardiologs (Paris, France), a medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
09 Mar 2021
Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
Philips Healthcare (Amsterdam?, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
Read More
20 Jan 2021
Philips Acquires Capsule Technologies to Expand Leadership in Patient Care Management Solutions for Hospitals
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Capsule Technologies, Inc. (Andover, MA, USA), a provider of medical device integration and data technologies for hospitals and healthcare organizations.
Read More
10 Mar 2020
Philips Receives Global AI for Enhanced Radiology Interpretation Company of The Year Award from Frost & Sullivan
 Philips Healthcare (Amsterdam?, Noord-Holland) has been recognized with the 2019 Global Company of the Year Award by Frost & Sullivan, based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced radiology interpretation market. Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Read More
05 Apr 2019
Philips Acquires Direct Radiology Teleradiology Platform
Royal Philips is expanding its radiology solutions portfolio with innovative teleradiology services, aimed at addressing the increasing shortage of radiologists, as well as the pressing need to improve access to precision diagnoses.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
22 Aug 2018
Intel and Philips Partner to Speed Up Imaging Analysis Using AI
Intel Corporation and Royal Philips have tested two healthcare use cases for deep learning inference models: one on X-rays of bones for bone-age-prediction modeling and the other on CT scans of lungs for lung segmentation. In these tests, which were conducted using Intel Xeon Scalable processors and the OpenVINO toolkit, the researchers achieved a speed improvement of 188 times for the bone-age-prediction model and 38 times for the lung-segmentation model over the baseline measurements. These tests show that healthcare organizations can implement artificial intelligence (AI) workloads without expensive hardware investments.
Read More

Additional news

30 Nov 2022
Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses
An increase in the number of people suffering from chronic illnesses, combined with an ever-growing elderly population, is expected to help the global multiparameter patient monitoring systems market register a CAGR of 5.8% over the 2022-2028 period to reach USD 15.5 billion by 2028.
Read More
23 Nov 2022
Global Visualization Instruments for MIS Market Driven by Increasing Demand for Endoscopy Procedures
The increasing demand for visualization systems for complex surgical procedures, growing demand for minimally invasive surgeries, and rising prevalence of chronic diseases are expected to help the global visualization instruments for minimally invasive surgery (MIS) market register a CAGR of 7.2% between 2022 and 2031 and reach a value of USD 21 billion by 2031.
Read More
11 Nov 2022
Global Diagnostic ECG Market Driven by Increased Incidence of Cardiac Diseases
The rising prevalence of such chronic conditions is necessitating the need for diagnosis and treatment in order to keep track of the patient's daily medical condition and maintain medical records. This, coupled with rising hospitalization of the older population for the treatment of cardiac diseases, has increased the need for electrocardiograph (ECG) diagnosis.
Read More
11 Nov 2022
Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics
Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.
Read More
09 Nov 2022
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining panels, tissue staining, and imaging and analysis services.
Read More
08 Nov 2022
Global Infusion Pumps Market Driven by Increasing Incidence of Chronic Diseases
Rising demand for ambulatory infusion pumps in home care, increasing incidence of chronic diseases along with a rapid growth of the geriatric population, and growing number of surgical procedures being performed, are driving the growth of the global infusion pumps market. As a result, the market is projected to register a CAGR of 7% from USD 14.7 billion in 2022 to USD 20.5 billion by 2027.
Read More
07 Nov 2022
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
Mast Group Limited (Liverpool, UK) and Nanomix (Emeryville, CA, USA) have entered into a multi-region distribution agreement wherein Mast will market and distribute the Nan?mix eLab system in the UK, Germany, France, Ireland and South Africa.
Read More
07 Nov 2022
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
An expanded collaboration between two industry leaders will pave the way for the development of AI-enabled diagnostic testing that is more accurate and reliable than current U.S. tests for patients with chronic diseases, including kidney, cardiovascular, liver and neurologic conditions.
Read More
01 Nov 2022
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, driven by an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & non-profit organizations to introduce novel & innovative products to address the growing demand.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions